Atıf İçin Kopyala
Ulukaya E., ARI F., Dimas K., SARIMAHMUT M., Guney E., Sakellaridis N., ...Daha Fazla
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.137, sa.10, ss.1425-1434, 2011 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
137
Sayı:
10
-
Basım Tarihi:
2011
-
Doi Numarası:
10.1007/s00432-011-1021-1
-
Dergi Adı:
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1425-1434
-
Anahtar Kelimeler:
Lung cancer treatment, Palladium(II) and platinum(II) complexes, Necrosis, CYTOTOXIC ACTIVITY, CRYSTAL-STRUCTURE, ANTITUMOR AGENTS, CISPLATIN, PD(II), DNA, APOPTOSIS, PT(II), ASSAY, HEPATOTOXICITY
-
Bursa Uludağ Üniversitesi Adresli:
Evet
Özet
Purpose Treatment for lung cancer is still far from satisfying rates. Therefore, there is a need for novel anticancer agents. For this purpose, novel platinum and palladium complexes {[Pd(sac)(terpy)](sac).4H(2)O (Complex 1), [Pt(sac)(terpy)] (sac).5H(2)O (Complex 2), [PdCl(terpy)](sac).2H(2)O (Complex 3), [PtCl(terpy)](sac).2H(2)O (Complex 4)} have been tested against three different non-small cell lung cancer cell lines (A549, H1299, PC-3).